Genome-Wide Investigation of Short Tandem Repeat Variation in Autism Spectrum Disorder by Charlotte Michelle Nguyen a Thesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Downloaded from [266]
Patterns of DNA methylation on the human X chromosome and use in analyzing X-chromosome inactivation by Allison Marie Cotton B.Sc., The University of Guelph, 2005 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) January 2012 © Allison Marie Cotton, 2012 Abstract The process of X-chromosome inactivation achieves dosage compensation between mammalian males and females. In females one X chromosome is transcriptionally silenced through a variety of epigenetic modifications including DNA methylation. Most X-linked genes are subject to X-chromosome inactivation and only expressed from the active X chromosome. On the inactive X chromosome, the CpG island promoters of genes subject to X-chromosome inactivation are methylated in their promoter regions, while genes which escape from X- chromosome inactivation have unmethylated CpG island promoters on both the active and inactive X chromosomes. The first objective of this thesis was to determine if the DNA methylation of CpG island promoters could be used to accurately predict X chromosome inactivation status. The second objective was to use DNA methylation to predict X-chromosome inactivation status in a variety of tissues. A comparison of blood, muscle, kidney and neural tissues revealed tissue-specific X-chromosome inactivation, in which 12% of genes escaped from X-chromosome inactivation in some, but not all, tissues. X-linked DNA methylation analysis of placental tissues predicted four times higher escape from X-chromosome inactivation than in any other tissue. Despite the hypomethylation of repetitive elements on both the X chromosome and the autosomes, no changes were detected in the frequency or intensity of placental Cot-1 holes. -
Targeted Next-Generation Sequencing in Patients with Suggestive X-Linked Intellectual Disability
G C A T T A C G G C A T genes Article Targeted Next-Generation Sequencing in Patients with Suggestive X-Linked Intellectual Disability Nekane Ibarluzea 1,2 , Ana Belén de la Hoz 1,2, Olatz Villate 1,2,3, Isabel Llano 1,2,3 , Intzane Ocio 4, Itxaso Martí 5, Miriam Guitart 6, Elisabeth Gabau 6, Fernando Andrade 1,2, Blanca Gener 1,2,3 and María-Isabel Tejada 1,2,3,* 1 Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain; [email protected] (N.I.); [email protected] (A.B.d.l.H.); [email protected] (O.V.); [email protected] (I.L.); [email protected] (F.A.); [email protected] (B.G.) 2 Spanish Consortium for Research on Rare Diseases (CIBERER), 28029 Madrid, Spain 3 Genetics Service, Cruces University Hospital, Osakidetza Basque Health Service, 48903 Barakaldo, Spain 4 Department of Paediatric Neurology, Araba University Hospital, Osakidetza Basque Health Service, 01009 Gasteiz, Spain; [email protected] 5 Department of Paediatric Neurology, Donostia University Hospital, Osakidetza Basque Health Service, 20014 Donostia, Spain; [email protected] 6 Genetics Laboratory, Paediatric Unit, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain; [email protected] (M.G.); [email protected] (E.G.) * Correspondence: [email protected] Received: 3 December 2019; Accepted: 30 December 2019; Published: 2 January 2020 Abstract: X-linked intellectual disability (XLID) is known to contribute up to 10% of intellectual disability (ID) in males and could explain the increased ratio of affected males observed in patients with ID. -
The Changing Chromatome As a Driver of Disease: a Panoramic View from Different Methodologies
The changing chromatome as a driver of disease: A panoramic view from different methodologies Isabel Espejo1, Luciano Di Croce,1,2,3 and Sergi Aranda1 1. Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain 2. Universitat Pompeu Fabra (UPF), Barcelona, Spain 3. ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain *Corresponding authors: Luciano Di Croce ([email protected]) Sergi Aranda ([email protected]) 1 GRAPHICAL ABSTRACT Chromatin-bound proteins regulate gene expression, replicate and repair DNA, and transmit epigenetic information. Several human diseases are highly influenced by alterations in the chromatin- bound proteome. Thus, biochemical approaches for the systematic characterization of the chromatome could contribute to identifying new regulators of cellular functionality, including those that are relevant to human disorders. 2 SUMMARY Chromatin-bound proteins underlie several fundamental cellular functions, such as control of gene expression and the faithful transmission of genetic and epigenetic information. Components of the chromatin proteome (the “chromatome”) are essential in human life, and mutations in chromatin-bound proteins are frequently drivers of human diseases, such as cancer. Proteomic characterization of chromatin and de novo identification of chromatin interactors could thus reveal important and perhaps unexpected players implicated in human physiology and disease. Recently, intensive research efforts have focused on developing strategies to characterize the chromatome composition. In this review, we provide an overview of the dynamic composition of the chromatome, highlight the importance of its alterations as a driving force in human disease (and particularly in cancer), and discuss the different approaches to systematically characterize the chromatin-bound proteome in a global manner. -
Methylome Profiling of Healthy and Central Precocious Puberty Girls Danielle S
Bessa et al. Clinical Epigenetics (2018) 10:146 https://doi.org/10.1186/s13148-018-0581-1 RESEARCH Open Access Methylome profiling of healthy and central precocious puberty girls Danielle S. Bessa1, Mariana Maschietto2, Carlos Francisco Aylwin3, Ana P. M. Canton1,4, Vinicius N. Brito1, Delanie B. Macedo1, Marina Cunha-Silva1, Heloísa M. C. Palhares5, Elisabete A. M. R. de Resende5, Maria de Fátima Borges5, Berenice B. Mendonca1, Irene Netchine4, Ana C. V. Krepischi6, Alejandro Lomniczi3,7, Sergio R. Ojeda7 and Ana Claudia Latronico1,8* Abstract Background: Recent studies demonstrated that changes in DNA methylation (DNAm) and inactivation of two imprinted genes (MKRN3 and DLK1) alter the onset of female puberty. We aimed to investigate the association of DNAm profiling with the timing of human puberty analyzing the genome-wide DNAm patterns of peripheral blood leukocytes from ten female patients with central precocious puberty (CPP) and 33 healthy girls (15 pre- and 18 post-pubertal). For this purpose, we performed comparisons between the groups: pre- versus post-pubertal, CPP versus pre-pubertal, and CPP versus post-pubertal. Results: Analyzing the methylome changes associated with normal puberty, we identified 120 differentially methylated regions (DMRs) when comparing pre- and post-pubertal healthy girls. Most of these DMRs were hypermethylated in the pubertal group (99%) and located on the X chromosome (74%). Only one genomic region, containing the promoter of ZFP57, was hypomethylated in the pubertal group. ZFP57 is a transcriptional repressor required for both methylation and imprinting of multiple genomic loci. ZFP57 expression in the hypothalamus of female rhesus monkeys increased during peripubertal development, suggesting enhanced repression of downstream ZFP57 target genes. -
Prevalence and Phenotypic Characterization of Rare Genetic Disorders Within Psychiatric Populations
Prevalence and Phenotypic Characterization of Rare Genetic Disorders within Psychiatric Populations by Venuja Sriretnakumar A thesis submitted in conformity with the requirements for the degree of Doctorate of Philosophy Graduate Department of Laboratory Medicine and Pathobiology University of Toronto © Copyright by Venuja Sriretnakumar 2021 Prevalence and Phenotypic Characterization of Rare Genetic Disorders within Psychiatric Populations Venuja Sriretnakumar Doctorate of Philosophy Laboratory Medicine and Pathobiology University of Toronto 2021 Abstract Many rare genetic syndromes are known to phenotypically manifest with psychiatric symptoms that can be indistinguishable from primary psychiatric disorders. While the majority of ongoing research in psychiatric genetics has been dedicated to the identification and characterization of genes involved in primary psychiatric disorders, there has been a lack of research to determine the extent to which rare genetic variants contribute to the overall psychiatric disease load. This thesis aims to investigate the prevalence of clinically well-characterized pathogenic copy number variant (CNV) syndromes and treatable genetic disorders that can present with neuropsychiatric symptoms within the general psychiatric patient population. In our first study, a greater than expected number of syndromic CNVs was observed amongst a cohort of 348 schizophrenia patients. In our second, pilot, study of 2 046 psychiatric patients, an enrichment for variants associated with four treatable inborn errors of metabolism were found in comparison to the control population. In the third, expansion, study ii screening for 108 treatable genetic disorders, there was also an enrichment found for the screened genetic disorders in a general psychiatric patient population relative to the expected disease prevalence in the general population. Moreover, an increased carrier frequency for screened genetic disorders was also seen amongst psychiatric patients. -
Attractor Metafeatures and Their Application in Biomolecular Data Analysis
Attractor Metafeatures and Their Application in Biomolecular Data Analysis Tai-Hsien Ou Yang Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2018 ©2018 Tai-Hsien Ou Yang All rights reserved ABSTRACT Attractor Metafeatures and Their Application in Biomolecular Data Analysis Tai-Hsien Ou Yang This dissertation proposes a family of algorithms for deriving signatures of mutually associated features, to which we refer as attractor metafeatures, or simply attractors. Specifically, we present multi-cancer attractor derivation algorithms, identifying correlated features in signatures from multiple biological data sets in one analysis, as well as the groups of samples or cells that exclusively express these signatures. Our results demonstrate that these signatures can be used, in proper combinations, as biomarkers that predict a patient’s survival rate, based on the transcriptome of the tumor sample. They can also be used as features to analyze the composition of the tumor. Through analyzing large data sets of 18 cancer types and three high-throughput platforms from The Cancer Genome Atlas (TCGA) PanCanAtlas Project and multiple single-cell RNA-seq data sets, we identified novel cancer attractor signatures and elucidated the identity of the cells that express these signatures. Using these signatures, we developed a prognostic biomarker for breast cancer called the Breast Cancer Attractor Metagenes (BCAM) biomarker as well as a software platform -
Public Version.Pdf
Dedicated to my father 1952 – 2013 Abstract While the aetiology and pathogenesis of cancer is variable and dependent on the initial cellular and carcinogenic environment, all manifestations of the disease are unified by a gross dysfunction of normal epigenetic control. Recent technological advances have revealed epigenomic disruption of large domains that encompass multiple genes, as well as a deregulation of spatial and temporal control of DNA in the nucleus. Here I consolidate these findings by identifying large genomic domains that are epigenetically and transcriptionally activated in prostate tumourigenesis, a phenomenon we termed Long Range Epigenetic Activation (LREA). These regions contain oncogenes, miRNAs and multiple prostate cancer biomarkers, such as prostate cancer antigen 3 (PCA3) and the prostate specific antigen (PSA). LREA regions are characterised by an increase of histone modifications H3K4me3 and H3K9ac with a simultaneous depletion of H3K27me3 at gene promoters. While I found little evidence of CpG island hypomethylation causing gene activation, I identified hypermethylation of CpG-islands associated with gene activation and differential promoter usage in prostate cancer. The presence of both epigenetically activated and repressed domains in prostate cancer indicates the deregulation of superior, “long-range” acting processes such as chromatin looping or the timing of DNA replication. Using the Kallikrein gene family locus, I describe the presence of chromatin loops anchored by the CTCF protein that commonly demarcate the limits of this cancer-specific regional epigenetic modulation. To investigate how replication timing can influence the cancer epigenome I optimised and carried out the high-resolution “Repli-seq” technique, which details the time of replication for all genomic loci.